7 completed, 5 unknown, 2 terminated, 1 active not recruiting. 16 Phase 2, 4 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 16 | Completed 7, Unknown 5, Terminated 2, Active not recruiting 1, Recruiting 1 |
| Phase 3 | 4 | Unknown 3, Completed 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Lactoferrin: new trials by email Literature Review of Lactoferrin trials Research Report on Lactoferrin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Management of Iron Deficiency Anemia in Hemodialysis Patients Lactoferrin, IV iron sucrose - Iron Deficiency Anemia (IDA), ESRD (End Stage Renal Disease) | Phase 2 | Active not recruiting | Beni-Suef University | 108 | 2025-11-02 | 2026-10-30 |
| Lactoferrin Supplementation in Diabetic Nephropathy Lactoferrin, Antidiabetic, Placebo - Diabetic Nephropathy | Phase 2 | Recruiting | Ain Shams University | 60 | 2025-08-01 | 2026-08-14 |
| Metformin and Lactoferrin in Sepsis in Icu Metformin, Lactoferrin - Sepsis | Phase 2 / Phase 3 | Unknown | Tanta University | 60 | 2024-04-01 | 2024-04-19 |
| Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Pregnancy lactoferrin - Bacterial Vaginosis | Vaginal | Microbiology | Phase 2 / Phase 3 | Unknown | Zagazig University | 66 | 2022-07-01 | 2023-01-03 |
| Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease Lactoferrin (Apolactoferrin), Placebo of excipient(s) will be administered - Corona Virus Infection, Middle East Respiratory Syndrome (MERS) | Phase 2 | Unknown | National Research Centre, Egypt | 516 | 2022-02-01 | 2021-11-15 |
| An Outpatient Study Investigating Non-prescription Treatments for COVID-19 chlorine dioxide, zinc acetate, Famotidine - COVID-19 | Phase 2 | Terminated | Profact, Inc. | 10 | 2020-11-15 | 2022-09-30 |
| Lactoferrin for Prevention of COVID-19 in Health Care Workers Bovine Lactoferrin, Maltodextrin - SARS-CoV-2 | Phase 2 | Terminated | Universidad Peruana Cayetano Heredia | 209 | 2020-10-17 | 2021-12-09 |
| Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19 Lactoferrin - COVID-19 | Phase 2 / Phase 3 | Unknown | Cairo University | 150 | 2020-06-01 | 2020-06-09 |
| Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy Lactoferrin and ferrous fumarate - Iron Deficiency Anemia of Pregnancy | Phase 1 / Phase 2 | Unknown | Assiut University | 150 | 2018-11-01 | 2018-07-03 |
| Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students Lactoferrin, Ferrous sulfate - Iron Deficiency Anemia | Phase 2 / Phase 3 | Completed | yasmin gamal el gendy | 90 | 2018-09-10 | 2020-05-28 |
| Lactoferrin Versus Ferrous Sulfate in Iron-deficiency During Pregnancy Baseline ferritin level, Lactoferrin, Ferrous Sulfate - Iron Deficiency Anemia | Phase 2 | Completed | Ain Shams University | 98 | 2018-01-15 | 2018-11-30 |
| Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing Oral lactoferrin, TDI of LMW iron dextran - Iron Deficiency Anemia | Phase 1 / Phase 2 | Completed | Woman's Health University Hospital, Egypt | 99 | 2017-11-01 | 2020-10-27 |
| Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy Lactoferrin, ferrous sulphate + folic acid (vitamin B9) - Iron Deficiency Anemia of Pregnancy | Phase 2 | Completed | Ain Shams Maternity Hospital | 200 | 2017-09-01 | 2018-03-29 |
| Effects of Vaginal Lactoferrin Administration Prior to Genetic Amniocentesis on Inflammatory Mediators Lactoferrin - Pregnancy | Phase 2 | Completed | Università degli Studi di Ferrara | 111 | 2014-01-01 | 2016-03-04 |
| Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL Study Lactoferrin, Placebo - Critically Ill | Phase 2 | Completed | Queen's University | 214 | 2013-11-01 | 2017-02-20 |
| Pilot Study: Lactoferrin for Prevention of Neonatal Sepsis lactoferrin, Maltodextrin - Sepsis | Phase 2 | Completed | Universidad Peruana Cayetano Heredia | 190 | 2010-12-01 | 2012-09-10 |
Anemia, Iron-Deficiency (4) · COVID-19 (4) · Sepsis (2) · Coronavirus Infections (1) · Critical Illness (1) · Cytokine Release Syndrome (1) · Diabetic Nephropathies (1) · Infections (1) · Renal Insufficiency, Chronic (1) · Respiratory Distress Syndrome (1) · Vaginosis, Bacterial (1)
Ain Shams University (2) · Universidad Peruana Cayetano Heredia (2) · Ain Shams Maternity Hospital (1) · Assiut University (1) · Beni-Suef University (1) · Cairo University (1) · National Research Centre, Egypt (1) · Profact, Inc. (1) · Queen's University (1) · Tanta University (1) · Università degli Studi di Ferrara (1) · Woman's Health University Hospital, Egypt (1) · Zagazig University (1) · yasmin gamal el gendy (1)
Egypt (9) · Peru (2) · Canada (1) · Italy (1) · United States (1)
Ahmed Mamdouh (1) · Alaa Hemida (1) · Amal Mohamed Alanwar, MD (1) · Carlo Contini, Professor (1) · Ghada Mohamed, MBBCh (1) · John G Muscedere, MD (1) · Jonathan Murphy, MD, MD(H) (1) · Marian Asaad Gerges, MD (1) · Marina E Albert, Bachelor of Pharmacy (1) · Rania Samy Ezzat, MD (1) · Rehab Hegazy, PhD (1) · Safaa Abdelsalam Ibrahim, MD (1) · Theresa J Ochoa, MD (1) · Theresa J Ochoa, MD, PhD (1)
PMID 25973934, PMID 27872513, PMID 33015104, PMID 34473343, PMID 36474100